Shares of Viveve Medical Inc (NASDAQ:VIVE) gapped up prior to trading on Monday . The stock had previously closed at $0.76, but opened at $0.69. Viveve Medical shares last traded at $0.62, with a volume of 9096 shares.

A number of analysts recently weighed in on the stock. Maxim Group reaffirmed a “buy” rating on shares of Viveve Medical in a report on Thursday, January 17th. Mizuho reissued a “buy” rating and set a $4.00 target price on shares of Viveve Medical in a research note on Friday, March 15th. Finally, Craig Hallum set a $1.00 target price on shares of Viveve Medical and gave the company a “hold” rating in a research note on Friday, January 18th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $4.00.

The company has a current ratio of 3.89, a quick ratio of 3.51 and a debt-to-equity ratio of 6.21. The stock has a market cap of $26.84 million, a price-to-earnings ratio of -0.38 and a beta of 0.70.

Large investors have recently bought and sold shares of the company. Geode Capital Management LLC raised its position in shares of Viveve Medical by 13.6% in the fourth quarter. Geode Capital Management LLC now owns 216,566 shares of the company’s stock valued at $227,000 after purchasing an additional 25,975 shares during the period. RTW Investments LP grew its stake in shares of Viveve Medical by 42.4% in the fourth quarter. RTW Investments LP now owns 4,480,565 shares of the company’s stock worth $4,705,000 after acquiring an additional 1,333,333 shares during the last quarter. Nantahala Capital Management LLC grew its stake in shares of Viveve Medical by 66.7% in the fourth quarter. Nantahala Capital Management LLC now owns 6,581,465 shares of the company’s stock worth $6,911,000 after acquiring an additional 2,633,333 shares during the last quarter. Sargent Investment Group LLC acquired a new stake in shares of Viveve Medical in the fourth quarter worth $32,000. Finally, Bank of New York Mellon Corp grew its stake in shares of Viveve Medical by 266.6% in the fourth quarter. Bank of New York Mellon Corp now owns 45,223 shares of the company’s stock worth $47,000 after acquiring an additional 32,888 shares during the last quarter. Institutional investors own 60.99% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Viveve Medical (VIVE) Shares Gap Up to $0.69” was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright laws. The original version of this story can be read at https://theolympiareport.com/2019/04/15/viveve-medical-vive-shares-gap-up-to-0-69.html.

About Viveve Medical (NASDAQ:VIVE)

Viveve Medical, Inc designs, develops, manufactures, and markets medical devices for the non-invasive treatment of various post-partum conditions. The company offers Viveve System, a radio frequency generator, a reusable hand piece, and single-use treatment tip, as well as other consumable accessories.

Further Reading: What is the Coverage Ratio?

Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.